Evidence map›Paper›PMID 35256533›Full record

ArticleTobacco control2023

Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study.

Nicola McMeekin, Olivia Wu, Kathleen Anne Boyd, Ashley Brown, Emily J Tweed, Catherine Best, Peter Craig, Alastair H Leyland, Evangelia Demou, Tom Byrne and 5 more

Abstract read
In one paragraph

Article in Tobacco control, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nicola McMeekinHEHTA, Institute of Health and Wellbeing, University of Glasgow College of Medical, Veterinary and Life Sciences, Glasgow, UK nicola.mcmeekin@glasgow.ac.uk.ORCID 0000-0003-2918-8820
Olivia WuHEHTA, Institute of Health and Wellbeing, University of Glasgow College of Medical, Veterinary and Life Sciences, Glasgow, UK.
Kathleen Anne BoydHEHTA, Institute of Health and Wellbeing, University of Glasgow College of Medical, Veterinary and Life Sciences, Glasgow, UK.
Ashley BrownInstitute for Social Marketing and Health, University of Stirling, Stirling, UK.
Emily J TweedMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
Catherine BestInstitute for Social Marketing and Health, University of Stirling, Stirling, UK.ORCID 0000-0002-3652-2498
Peter CraigMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
Alastair H LeylandMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
Evangelia DemouMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
Tom ByrneHealthcare Improvement Scotland, Glasgow, UK.
Jill PellInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Sean SempleInstitute for Social Marketing and Health, University of Stirling, Stirling, UK.ORCID 0000-0002-0462-7295
Helen SweetingMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.ORCID 0000-0002-3321-5732
Lesley GrahamPublic Health Scotland, Edinburgh, UK.
Kate HuntInstitute for Social Marketing and Health, University of Stirling, Stirling, UK.ORCID 0000-0002-5873-3632

Funding

Cancer Research UK C45874/A27016Chief Scientist Office CAF/17/11Chief Scientist Office SPHSU13Chief Scientist Office SPHSU15Chief Scientist Office SPHSU17Department of Health 15/55/44Medical Research Council MC_PC_13027Medical Research Council MC_UU_00022/2Medical Research Council MC_UU_12017/13Medical Research Council MC_UU_12017/15
6 · The paper itself

Abstract

objectiveTo determine the cost-effectiveness of a smoke-free prison policy in Scotland, through assessments of the trade-offs between costs (healthcare and non-healthcare-related expenditure) and outcomes (health and non-health-related non-monetary consequences) of implementing the policy.

designA health economic evaluation consisting of three analyses (cost-consequence, cost-effectiveness and cost-utility), from the perspectives of the healthcare payer, prison service, people in custody and operational staff, assessed the trade-offs between costs and outcomes. Costs associated with the implementation of the policy, healthcare resource use and personal spend on nicotine products were considered, alongside health and non-health outcomes. The cost-effectiveness of the policy was evaluated over 12-month and lifetime horizons (short term and long term).

settingScotland's national prison estate.

participantsPeople in custody and operational prison staff.

interventionImplementation of a comprehensive (indoor and outdoor) smoke-free policy.

main outcome measuresConcentration of secondhand smoke, health-related quality of life (health utilities and quality-adjusted life-years (QALY)) and various non-health outcomes (eg, incidents of assaults and fires).

resultsThe short-term analyses suggest cost savings for people in custody and staff, improvements in concentration of secondhand smoke, with no consistent direction of change across other outcomes. The long-term analysis demonstrated that implementing smoke-free policy was cost-effective over a lifetime for people in custody and staff, with approximate cost savings of £28 000 and £450, respectively, and improvement in health-related quality of life of 0.971 QALYs and 0.262, respectively.

conclusionImplementing a smoke-free prison policy is cost-effective over the short term and long term for people in custody and staff.

Indexed as

Smoke-Free PolicyTobacco Smoke PollutionCost-Benefit AnalysisHumansPrisonsQuality of LifeTobacco ProductsTobacco Smoke Pollutioneconomicspublic policysecondhand smoke

Identifiers

PMID35256533
PMCPMC7615232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.